- Tytuł:
- Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
- Autorzy:
- Źródło:
-
In
Lancet Oncology July 2014 15(8):829-840
Czasopismo naukowe